Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2008
11/27/2008WO2007117509A3 High delivery rates for lipid based drug formulations, and methods of treatment thereof
11/27/2008WO2007021822A3 Compositions and methods of preparation of liposomal microparticulate il-12
11/27/2008WO2006035275A3 A method for protecting implantable sensors and protected implantable sensors
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080294148 System and method for refilling an implanted delivery device
11/27/2008US20080294100 Pharmaceutical Device For the Administration of Substrates to Patients
11/27/2008US20080293817 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
11/27/2008US20080293805 Drug delivery system and the preparing method thereof
11/27/2008US20080293803 Melatonin daily dosage units
11/27/2008US20080293801 Solid Amorphous Dispersions of An Mtp Inhibitor For Treatment of Obesity
11/27/2008US20080293796 Parenteral and oral formulations of benzimidazoles
11/27/2008US20080293734 Pharmaceutical compositions
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293633 Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary Syndromes
11/27/2008US20080293121 Human dnase i hyperactive variants
11/27/2008US20080292714 Bone targeting of degradable drug filled nanoparticles
11/27/2008US20080292713 Respirable Powders
11/27/2008US20080292712 Methods and compositions for enhanced delivery of bioactive molecules
11/27/2008US20080292710 Liquid Dosage Forms Of Acid Labile Drugs
11/27/2008US20080292709 Kits for dhea and dhea-sulfate for the treatment of chronic obstructive pulmonary disease
11/27/2008US20080292708 Polymeric Adhesive Matrix with Salified Carboxylic Groups for Transdermal Use
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292706 Hydrogel composition and methods for making the same
11/27/2008US20080292705 Emulsifier system
11/27/2008US20080292704 Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins
11/27/2008US20080292703 Antitumoral Bioconjugates of Hyaluronic Acid or Its Derivatives Obtained by Indirect Chemical Conjugation, and Their Use in the Pharmaceutical Field
11/27/2008US20080292702 Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising Same
11/27/2008US20080292701 Lansoprazole dosage forms; fast disintegration in the oral cavity even without water
11/27/2008US20080292700 Controlled release formulations using intelligent polymers
11/27/2008US20080292699 Solid pharmaceutical dosage unit for alleviating symptoms of rhinorrhea
11/27/2008US20080292698 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
11/27/2008US20080292697 Direct compression polymer tablet core
11/27/2008US20080292696 Enteric Sustained-Release Tablet Comprising Paroxetine
11/27/2008US20080292695 Carvedilol forms, compositions, and methods of preparation thereof
11/27/2008US20080292694 Opioid agonist/antagonist combinations
11/27/2008US20080292693 Composition and method for treating digestive system disorders
11/27/2008US20080292692 Impermeable Capsules
11/27/2008US20080292691 Bariatric magnetic apparatus and method of manufacturing thereof
11/27/2008US20080292690 Multi-membrane immunoisolation system for cellular transplant
11/27/2008US20080292689 Method for inhibiting free radicals
11/27/2008US20080292688 Liposome and preparation method of the same
11/27/2008US20080292687 Methods of Treating Cancer and Other Conditions or Disease States Using Lfmau and Ldt
11/27/2008US20080292686 Vaccine
11/27/2008US20080292685 Transdermal Patch Containing Isosorbide Dinitrate and Bisoprolol
11/27/2008US20080292684 Device for Delivery of Active Principles
11/27/2008US20080292683 Film shreds and delivery system incorporating same
11/27/2008US20080292682 Method for treating allergic dermatitis
11/27/2008US20080292680 Hypercompressed polymer particles for controlled release ophthalmic medications
11/27/2008US20080292677 Engineered lung tissue, hydrogel/somatic lung progenitor cell constructs to support tissue growth, and method for making and using same
11/27/2008US20080292675 Antimicrobial medicotechnical product, process for its production and use
11/27/2008US20080292670 Adhesive and plaster
11/27/2008US20080292668 Water-Free Cosmetic Preparation
11/27/2008US20080292667 Nonwoven Nanofibrous Membranes of Silk Fibroin for Guided Bone Tissue Regeneration and Their Preparation Method
11/27/2008US20080292666 Preparation for Preventing or Treating Calcium Deficiency Conditions In Mammals
11/27/2008US20080292665 Simple mechanical procedure and product for deterring substance abuse
11/27/2008US20080292664 Hydrogels and Hyaluronic Acid and Alpha, Beta-Polyaspartyl-Hydrazide and Their Biomedical and Pharmaceutical Uses
11/27/2008US20080292611 Novel methods of treatment and delivery modes
11/27/2008US20080292610 Medicaments containing enzymes from ciliates for promoting digestion in digestive disorders
11/27/2008US20080292606 Pharmaceutical Oral Dosage Form Comprising a Non-Steroidal Anti-Inflammatory Drug, and Having Good Palatability
11/27/2008US20080292580 Treatment of Inflammatory Diseases
11/27/2008US20080292566 Oral composition containing morin
11/27/2008US20080292564 Aerosol compositions containing fluorine substituted olefins and methods and systems using same
11/27/2008US20080292563 Inhalable Powder Containing Tiotropium
11/27/2008US20080292562 Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts
11/27/2008US20080292561 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents
11/27/2008US20080292560 Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
11/27/2008US20080292559 Method of treating tuberculosis with interferons
11/27/2008US20080292545 Functionalized Encoded Apoferritin Nanoparticles and Processes for Making and Using Same
11/27/2008US20080290326 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process
11/27/2008US20080289630 Pre-metered dry powder inhaler for moisture-sensitive medicaments
11/27/2008DE112007000162T5 Laminiertes Mikrokapselblatt und Verfahren zu deren Herstellung Laminated microcapsule sheet and process for their preparation
11/27/2008DE102007023399A1 Kapsel zur Aufnahme eines Mediums sowie Verfahren zur Herstellung einer derartigen Kapsel Capsule for receiving a medium as well as methods for producing such a capsule
11/27/2008CA2704111A1 Hypercompressed particles for controlled release of ophthalmic medications
11/27/2008CA2688812A1 Highly charged microcapsules
11/27/2008CA2688721A1 Stable pharmaceutical formulation for a dpp-iv inhibitor
11/27/2008CA2688011A1 Hydrogel implant for sensing metabolites in body tissue
11/27/2008CA2687956A1 Method for producing pharmaceutical tablet
11/27/2008CA2687955A1 Crystalline micropowder particles
11/27/2008CA2687630A1 Self-emulsifying formulation of tipranavir for oral administration
11/27/2008CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008CA2687264A1 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
11/27/2008CA2687239A1 Poultice and process for producing the poultice
11/27/2008CA2686720A1 Drug delivery system with scleral lens
11/27/2008CA2686488A1 Colored esmolol concentrate
11/27/2008CA2686286A1 Transdermal delivery devices assuring an improved release of an active principle through a biological interface
11/27/2008CA2686137A1 Improved depot formulations
11/27/2008CA2684366A1 Controlled release tablet formulation containing magnesium aluminometasilicate
11/27/2008CA2683935A1 An extended-release composition comprising a somatostatin derivative in microparticles
11/27/2008CA2683020A1 Oral dosage form providing fast absorption of drug
11/27/2008CA2680433A1 Novel composition based on cholest-4-ene-3-one oxime
11/27/2008CA2677743A1 Lotion composition for personal use
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994934A1 Therapeutic agent for degenerative arthritis
11/26/2008EP1994933A1 Aqueous composition
11/26/2008EP1994926A1 Valsartan formulations
11/26/2008EP1994925A1 Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation
11/26/2008EP1994924A1 A compound for treating, either in a natural or synthetic manner, bacterial or viral inflammatory pathologies of the throat, in the presence of xerostomy
1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 2991